Evaluation of Treatment Thresholds for Unconjugated Hyperbilirubinemia in Preterm Infants: Effects on Serum Bilirubin and on Hearing Loss?

被引:11
|
作者
Hulzebos, Christian V. [1 ]
van Dommelen, Paula [2 ]
Verkerk, Paul H. [2 ]
Dijk, Peter H. [1 ]
Van Straaten, Henrica L. M. [3 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat, Div Neonatol, Groningen, Netherlands
[2] TNO, Dept Behav & Societal Sci, Leiden, Netherlands
[3] Isala Clin Zwolle, Dept Pediat, Div Neonatol, Zwolle, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 05期
关键词
LOW-BIRTH-WEIGHT; BRAIN-STEM RESPONSE; VS. CONSERVATIVE PHOTOTHERAPY; UNBOUND BILIRUBIN; NEURODEVELOPMENTAL OUTCOMES; RISK-FACTORS; ASSOCIATION;
D O I
10.1371/journal.pone.0062858
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Severe unconjugated hyperbilirubinemia may cause deafness. In the Netherlands, 25% lower total serum bilirubin (TSB) treatment thresholds were recently implemented for preterm infants. Objective: To determine the rate of hearing loss in jaundiced preterms treated at high or at low TSB thresholds. Design/Methods: In this retrospective study conducted at two neonatal intensive care units in the Netherlands, we included preterms (gestational age <32 weeks) treated for unconjugated hyperbilirubinemia at high or low TSB thresholds. Infants with major congenital malformations, syndromes, chromosomal abnormalities or toxoplasmosis, rubella, cytomegalovirus, herpes, syphilis, and human immunodeficiency infections were excluded. We analyzed clinical characteristics and TSB levels during the first ten postnatal days. After two failed automated Auditory Brainstem Response (ABR) tests we used the results of the diagnostic ABR examination to define normal, unilateral, and bilateral hearing loss (>35 dB). Results: There were 479 patients in the high and 144 in the low threshold group. Both groups had similar gestational ages (29.5 weeks) and birth weights (1300 g). Mean and mean peak TSB levels were significantly lower after the implementation of the novel thresholds: 152 +/- 43 mu mol/L and 212 +/- 52 mu mol/L versus 131 +/- 37 mu mol/L and 188 +/- 46 mu mol/L for the high versus low thresholds, respectively (P<0.001). The incidence of hearing loss was 2.7% (13/479) in the high and 0.7% (1/144) in the low TSB threshold group (NNT = 50, 95% CI, 25-3302). Conclusions: Implementation of lower treatment thresholds resulted in reduced mean and peak TSB levels. The incidence of hearing impairment in preterms with a gestational age <32 weeks treated at low TSB thresholds was substantially lower compared to preterms treated at high TSB thresholds. Further research with larger sample sizes and power is needed to determine if this effect is statistically significant.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Evaluation of the BiliChek Noninvasive Bilirubin Analyzer for Prediction of Serum Bilirubin and Risk of Hyperbilirubinemia
    Karon, Brad S.
    Teske, Ann
    Santrach, Paula J.
    Cook, Walter J.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 130 (06) : 976 - 982
  • [22] Hyponatremia and sensorineural hearing loss in preterm infants
    Ertl, T
    Hadzsiev, K
    Vincze, O
    Pytel, J
    Szabo, I
    Sulyok, E
    [J]. BIOLOGY OF THE NEONATE, 2001, 79 (02): : 109 - 112
  • [23] Hyperbilirubinemia in preterm infants in Japan: New treatment criteria
    Morioka, Ichiro
    [J]. PEDIATRICS INTERNATIONAL, 2018, 60 (08) : 684 - 690
  • [24] Effects of hearing loss on echo thresholds
    Roberts, RA
    Besing, J
    Koehnke, J
    [J]. EAR AND HEARING, 2002, 23 (04): : 349 - 357
  • [25] NEURODEVELOPMENT OF PRETERM INFANTS - NEONATAL NEUROSONOGRAPHIC AND SERUM BILIRUBIN STUDIES
    GRAZIANI, LJ
    MITCHELL, DG
    KORNHAUSER, M
    PIDCOCK, FS
    MERTON, DA
    STANLEY, C
    MCKEE, L
    [J]. PEDIATRICS, 1992, 89 (02) : 229 - 234
  • [26] EFFECT OF TRANSFUSIONS ON SERUM BILIRUBIN LEVELS IN SICK PRETERM INFANTS
    SASIDHARAN, P
    MARQUEZ, E
    DIZON, E
    SRIDHAR, CV
    [J]. PEDIATRIC RESEARCH, 1986, 20 (04) : A260 - A260
  • [27] SEQUENTIAL TRIAL OF EFFECT OF PHENOBARBITONE ON SERUM BILIRUBIN OF PRETERM INFANTS
    CARSWELL, F
    DUNSMORE, IR
    KERR, MM
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1972, 47 (254) : 621 - &
  • [28] Transcutaneous versus Total Serum Bilirubin Measurements in Preterm Infants
    Jegathesan, Thivia
    Campbell, Douglas M.
    Ray, Joel G.
    Shah, Vibhuti
    Berger, Howard
    Hayeems, Robin Z.
    Sgro, Michael
    [J]. NEONATOLOGY, 2021, 118 (04) : 443 - 453
  • [29] Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants
    Fuchs, Aline
    Zimmermann, Lara
    Graz, Myriam Bickle
    Cherpillod, Jacques
    Tolsa, Jean-Francois
    Buclin, Thierry
    Giannoni, Eric
    [J]. PLOS ONE, 2016, 11 (07):
  • [30] Risk factors of sensorineural hearing loss in preterm infants
    Anagnostakis, D
    Messaritakis, J
    Mandyla, H
    [J]. BIOLOGY OF THE NEONATE, 1997, 72 (05): : 327 - 328